GCGR and liver cancer: We performed coimmunoprecipitation experiments in HEPG2 human liver cancer cell lines that were transfected with human glucagon receptor-GFP + human ARRDC4-FLAG or glucagon receptor + empty vector controls and treated with glucagon or PBS.